The discovery of new treatments often begins with basic research into the biological mechanisms driving cancer. Scientists study genetic mutations, cellular pathways, and the tumor microenvironment. Preclinical studies in laboratories and animal models help identify potential targets for treatment, which are then tested in clinical trials to evaluate their safety and efficacy in humans.
